Jenburkt Pharmaceuticals has launched antiviral drug Favipiravir under the brand name 'Favivent' for the treatment of mild to moderate COVID-19 symptoms at a price of ₹39 per tablet. The tablet will be available in 200 mg strength in the form of a strip of 10 tablets, it added. The drug will be manufactured at a pharmaceutical plant in Telangana.